REWATI BHATTARAI: Open Payments
NPI 1215545157 · OSWEGO, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,387 in 68 payments from 12 companies in 2025. Trend: 2023 $914 · 2024 $892 · 2025 $1,387
Food & beverage: $1,274Education: $113
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $353 |
| Janssen Biotech, Inc. | 5 | $302 |
| Gilead Sciences, Inc. | 9 | $169 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $146 |
| Madrigal Pharmaceuticals | 2 | $90 |
| Ipsen Biopharmaceuticals, Inc | 5 | $87 |
| Lilly USA, LLC | 4 | $73 |
| Phathom Pharmaceuticals, Inc. | 3 | $49 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $37 |
| GENZYME CORPORATION | 1 | $33 |
Products named: TREMFYA, RINVOQ, ENTYVIO, REZDIFFRA, IQIRVO, MAVYRET, OMVOH, VOQUEZNA.
Industry payments across NY — which companies pay providers there.
